Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (31086)	9/26/2006 12:32:44 AM
From: Baton	Read Replies (3) \| Respond to of 48461

I never owned Vaxgen, which went from below $2 to nearly $20 on news of it's DOD contract. From what I can gather, the mngmnt at PharmAthene is very sharp and are doing things the right way. SIGA has a very small following and as news gets out over the next few days, I'd expect several good tradable spikes as well as chances to reload. Overall, I think the safe thing is to keep a good core position. Of all the biotech companies PharmAthene could have partnered with, they chose SIGA. I wanna be in the stock the day the smallpox contracts are awarded. However, that won't stop me from playing with a few shares if the odds look right. The merger proxy should follow within a few days, maybe sooner. FYI the lowdown on PharmAthene. pharmathene.com Baton